X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-06-09 | ABML | American Battery Metals Corp | Maclellan Douglas Charles | Dir | S - Sale | $2.35 | -400,000 | 9,264,717 | -4% | -$941,800 | |||||
| AM | 2021-06-09 | ABML | American Battery Metals Corp | Maclellan Douglas Charles | Dir | S - Sale | $2.35 | -350,000 | 9,264,717 | -4% | -$822,250 | |||||
| M | 2021-06-14 | ABML | American Battery Metals Corp | William John Hunter | Dir | S - Sale | $2.23 | -391,383 | 11,683,334 | -3% | -$873,324 | |||||
| M | 2021-06-01 | ABML | American Battery Metals Corp | Cole Douglas | CEO | S - Sale | $2.24 | -350,000 | 16,764,717 | -2% | -$785,400 | |||||
| M | 2021-06-07 | ABML | American Battery Metals Corp | Maclellan Douglas Charles | Dir | S - Sale | $2.08 | -400,000 | 9,614,717 | -4% | -$831,220 | |||||
| M | 2021-06-03 | ABML | American Battery Metals Corp | Cole Douglas | CEO | S - Sale | $2.11 | -400,000 | 16,364,717 | -2% | -$843,340 | |||||
2021-06-07 | AKBA | Akebia Therapeutics, Inc. | Gilman Steven C | Dir | S - Sale | $3.32 | -4,567 | 47,997 | -9% | -$15,163 | ||||||
| M | 2021-05-27 | ALJJ | Alj Regional Holdings Inc | Ravich Rae | Dir | S - Sale | $1.51 | -7,878 | 85,419 | -8% | -$11,891 | |||||
| M | 2021-05-25 | AMMJ | American Cannabis Company, Inc. | Smith Ellis Lamar | Chief Development Officer, 10% | S - Sale | $0.19 | -74,665 | 12,018,425 | -1% | -$13,922 | |||||
| M | 2021-05-27 | AMMJ | American Cannabis Company, Inc. | Smith Ellis Lamar | Chief Development Officer, 10% | S - Sale | $0.18 | -85,635 | 11,932,790 | -1% | -$15,588 | |||||
| D | 2021-05-21 | AMPE | Ampio Pharmaceuticals, Inc. | Coelho Philip H | Dir | S - Sale+OE | $2.00 | -6,737 | 203,500 | -3% | -$13,474 | |||||
| M | 2021-05-20 | AMST | Amesite Inc. | Tompkins Mark N. | 10% | S - Sale | $2.22 | -69,871 | 2,143,916 | -3% | -$154,792 | |||||
| M | 2021-05-25 | AMST | Amesite Inc. | Tompkins Mark N. | 10% | S - Sale | $2.30 | -47,497 | 2,096,419 | -2% | -$109,094 | |||||
| M | 2021-05-28 | AMST | Amesite Inc. | Tompkins Mark N. | 10% | S - Sale | $2.46 | -53,316 | 2,043,103 | -3% | -$131,224 | |||||
| D | 2021-05-26 | APRN | Blue Apron Holdings, Inc. | Deutsch Meredith L | GC, Corp. Sec'y | S - Sale+OE | $4.72 | -2,120 | 15,844 | -12% | -$10,017 | |||||
| D | 2021-05-26 | APRN | Blue Apron Holdings, Inc. | Kozlowski Linda F | Pres, CEO | S - Sale+OE | $4.72 | -6,165 | 92,219 | -6% | -$29,128 | |||||
| D | 2021-05-26 | APRN | Blue Apron Holdings, Inc. | Krechmer Irina | CTO | S - Sale+OE | $4.72 | -2,757 | 25,795 | -10% | -$13,026 | |||||
2021-05-27 | ASMB | Assembly Biosciences, Inc. | Delaney William E IV | Chief Scientific Officer | S - Sale | $4.03 | -4,129 | 53,121 | -7% | -$16,637 | ||||||
| DM | 2021-06-08 | ASXC | Asensus Surgical, Inc. | Fernando Anthony C. J. | Pres, CEO | S - Sale+OE | $3.10 | -297,794 | 324,820 | -48% | -$924,026 | |||||
2021-06-03 | ATAO | Altair International Corp. | Fourth Street Fund, LP | Owner of 45% of Issuer | S - Sale | $0.11 | -19,100,000 | 250,593,050 | -7% | -$2,101,000 | ||||||
2021-06-08 | ATHX | Athersys, Inc / New | Harrington John J | Exec Vice Pres, CSO | S - Sale | $1.75 | -27,107 | 672,395 | -4% | -$47,554 | ||||||
| D | 2021-06-15 | ATHX | Athersys, Inc / New | Harrington John J | Exec Vice Pres, CSO | S - Sale+OE | $1.55 | -20,767 | 784,961 | -3% | -$32,129 | |||||
| M | 2021-05-28 | ATHX | Athersys, Inc / New | Harrington John J | Exec Vice Pres, CSO | S - Sale | $1.75 | -20,447 | 699,502 | -3% | -$35,849 | |||||
| M | 2021-06-04 | BDR | Blonder Tongue Laboratories Inc | Palle Robert J Jr | Dir, 10% | S - Sale | $1.37 | -22,000 | 2,667,004 | -1% | -$30,120 | |||||
2021-06-10 | BDR | Blonder Tongue Laboratories Inc | Palle Robert J Jr | Dir, 10% | S - Sale | $1.36 | -20,000 | 2,624,004 | -1% | -$27,200 | ||||||
| M | 2021-06-08 | BDR | Blonder Tongue Laboratories Inc | Palle Robert J Jr | Dir, 10% | S - Sale | $1.37 | -23,000 | 2,644,004 | -1% | -$31,558 | |||||
| M | 2021-06-09 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Maria Ines | Chief Science Officer | S - Sale | $0.14 | -215,110 | 283,938,080 | 0% | -$31,158 | |||||
| M | 2021-06-14 | BPSR | Organicell Regenerative Medicine, Inc. | Shapiro George Craig | Chief Medical Officer | S - Sale | $0.15 | -143,454 | 80,614,142 | 0% | -$21,819 | |||||
| M | 2021-06-04 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Maria Ines | Chief Science Officer | S - Sale | $0.13 | -300,000 | 284,443,190 | 0% | -$39,630 | |||||
| M | 2021-05-21 | BPSR | Organicell Regenerative Medicine, Inc. | Shapiro George Craig | Chief Medical Officer | S - Sale | $0.19 | -156,504 | 81,488,396 | 0% | -$29,903 | |||||
| M | 2021-05-21 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Maria Ines | Chief Science Officer | S - Sale | $0.19 | -200,000 | 285,703,190 | 0% | -$37,750 | |||||
| M | 2021-05-21 | BPSR | Organicell Regenerative Medicine, Inc. | Bothwell Ian T | CFO, 10% | S - Sale | $0.19 | -200,000 | 149,168,726 | 0% | -$37,550 | |||||
| M | 2021-05-21 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Albert | Pres, 10% | S - Sale | $0.19 | -200,000 | 285,703,190 | 0% | -$37,700 | |||||
| M | 2021-06-04 | BPSR | Organicell Regenerative Medicine, Inc. | Bothwell Ian T | CFO, 10% | S - Sale | $0.14 | -300,000 | 148,538,726 | 0% | -$40,508 | |||||
| M | 2021-06-04 | BPSR | Organicell Regenerative Medicine, Inc. | Shapiro George Craig | Chief Medical Officer | S - Sale | $0.13 | -300,800 | 80,907,596 | 0% | -$39,801 | |||||
| M | 2021-06-14 | BPSR | Organicell Regenerative Medicine, Inc. | Bothwell Ian T | CFO, 10% | S - Sale | $0.15 | -190,000 | 148,068,726 | 0% | -$28,890 | |||||
| M | 2021-06-09 | BPSR | Organicell Regenerative Medicine, Inc. | Shapiro George Craig | Chief Medical Officer | S - Sale | $0.15 | -150,000 | 80,757,596 | 0% | -$21,850 | |||||
| M | 2021-05-26 | BPSR | Organicell Regenerative Medicine, Inc. | Bothwell Ian T | CFO, 10% | S - Sale | $0.18 | -190,000 | 148,978,726 | 0% | -$34,843 | |||||
| M | 2021-05-26 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Albert | Pres, 10% | S - Sale | $0.18 | -190,000 | 285,323,190 | 0% | -$34,967 | |||||
| M | 2021-05-26 | BPSR | Organicell Regenerative Medicine, Inc. | Shapiro George Craig | Chief Medical Officer | S - Sale | $0.18 | -140,000 | 81,348,396 | 0% | -$25,677 | |||||
| M | 2021-05-26 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Maria Ines | Chief Science Officer | S - Sale | $0.18 | -190,000 | 285,323,190 | 0% | -$34,870 | |||||
| M | 2021-06-14 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Albert | Pres, 10% | S - Sale | $0.15 | -190,000 | 283,598,080 | 0% | -$29,069 | |||||
| M | 2021-06-04 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Albert | Pres, 10% | S - Sale | $0.13 | -300,000 | 284,443,190 | 0% | -$39,900 | |||||
| M | 2021-06-01 | BPSR | Organicell Regenerative Medicine, Inc. | Bothwell Ian T | CFO, 10% | S - Sale | $0.18 | -140,000 | 148,838,726 | 0% | -$24,500 | |||||
| M | 2021-06-01 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Albert | Pres, 10% | S - Sale | $0.18 | -140,000 | 285,043,190 | 0% | -$24,700 | |||||
| M | 2021-06-01 | BPSR | Organicell Regenerative Medicine, Inc. | Shapiro George Craig | Chief Medical Officer | S - Sale | $0.18 | -140,000 | 81,208,396 | 0% | -$24,650 | |||||
| M | 2021-06-01 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Maria Ines | Chief Science Officer | S - Sale | $0.18 | -140,000 | 285,043,190 | 0% | -$24,522 | |||||
| M | 2021-06-14 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Maria Ines | Chief Science Officer | S - Sale | $0.15 | -150,000 | 283,598,080 | 0% | -$23,050 | |||||
| M | 2021-06-09 | BPSR | Organicell Regenerative Medicine, Inc. | Mitrani Albert | Pres, 10% | S - Sale | $0.14 | -290,000 | 283,938,080 | 0% | -$41,500 | |||||
| M | 2021-06-09 | BPSR | Organicell Regenerative Medicine, Inc. | Bothwell Ian T | CFO, 10% | S - Sale | $0.14 | -280,000 | 148,258,726 | 0% | -$39,750 | |||||
2021-06-04 | BSQR | Bsquare Corp /wa | Harries Andrew Stanley Guy | Dir | S - Sale | $2.75 | -25,000 | 298,628 | -8% | -$68,748 | ||||||
| M | 2021-06-09 | BSQR | Bsquare Corp /wa | Harries Andrew Stanley Guy | Dir | S - Sale | $2.74 | -15,000 | 283,628 | -5% | -$41,045 | |||||
| M | 2021-05-28 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.46 | -56,500 | 21,933,161 | 0% | -$26,024 | |||||
2021-05-27 | BWEN | Broadwind, Inc. | Wagner Thomas A. | Dir | S - Sale | $4.47 | -20,000 | 70,685 | -22% | -$89,356 | ||||||
| M | 2021-05-21 | CBDS | Cannabis Sativa, Inc. | Herr Brad E | CFO | S - Sale | $0.55 | -26,200 | 365,177 | -7% | -$14,322 | |||||
| M | 2021-06-07 | CSLT | Castlight Health, Inc. | Cohen Seth B. | Dir | S - Sale | $2.11 | -70,000 | 228,222 | -23% | -$147,912 | |||||
| M | 2021-05-21 | CVV | Cvd Equipment Corp | Teitelbaum Martin J | No longer a Director/Officer | S - Sale | $4.31 | -2,825 | 70,172 | -4% | -$12,171 | |||||
| M | 2021-05-28 | CVV | Cvd Equipment Corp | Rosenbaum Leonard A | Dir, 10% | S - Sale | $4.27 | -75,000 | 751,548 | -9% | -$320,298 | |||||
| D | 2021-05-21 | CWRK | Currencyworks Inc. | Chell Cameron | Dir | S - Sale+OE | $1.42 | -250,000 | 2,272,000 | -10% | -$355,000 | |||||
| DM | 2021-06-07 | DYAI | Dyadic International Inc | Emalfarb Mark A | Pres, CEO, 10% | S - Sale+OE | $3.86 | -97,000 | 12,827,751 | -1% | -$373,960 | |||||
| DM | 2021-06-02 | DYAI | Dyadic International Inc | Emalfarb Mark A | Pres, CEO, 10% | S - Sale+OE | $3.79 | -235,070 | 12,327,751 | -2% | -$890,208 | |||||
| M | 2021-05-24 | ELVT | Elevate Credit, Inc. | Head Tyler W. K. | Dir | S - Sale | $3.79 | -108,513 | 536,739 | -17% | -$411,449 | |||||
2021-06-14 | ELVT | Elevate Credit, Inc. | Tcv V LP | May be part of a 13(g) group, 10% | S - Sale | $3.40 | -1,380,000 | 3,224,888 | -30% | -$4,692,000 | ||||||
| M | 2021-05-27 | ELVT | Elevate Credit, Inc. | Head Tyler W. K. | Dir | S - Sale | $3.72 | -31,317 | 505,422 | -6% | -$116,390 | |||||
| M | 2021-06-04 | ELVT | Elevate Credit, Inc. | Head Tyler W. K. | Dir | S - Sale | $3.90 | -85,000 | 330,422 | -20% | -$331,244 | |||||
2021-06-15 | ELVT | Elevate Credit, Inc. | Greever Scott | Chief Product Officer | S - Sale | $3.70 | -5,000 | 86,156 | -5% | -$18,500 | ||||||
2021-06-07 | ELVT | Elevate Credit, Inc. | Harvison Jason | Pres, CEO | S - Sale | $3.86 | -15,000 | 416,887 | -3% | -$57,900 | ||||||
| M | 2021-06-01 | ELVT | Elevate Credit, Inc. | Head Tyler W. K. | Dir | S - Sale | $3.95 | -90,000 | 415,422 | -18% | -$355,800 | |||||
| M | 2021-06-09 | ELVT | Elevate Credit, Inc. | Head Tyler W. K. | Dir | S - Sale | $3.77 | -55,000 | 275,422 | -17% | -$207,221 | |||||
| M | 2021-05-20 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $2.45 | -72,441 | 2,164,448 | -3% | -$177,232 | |||||
| M | 2021-06-04 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $3.71 | -49,131 | 1,519,737 | -3% | -$182,293 | |||||
| M | 2021-05-24 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $2.45 | -41,277 | 2,123,171 | -2% | -$100,975 | |||||
| M | 2021-06-15 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $4.03 | -225,080 | 1,371,930 | -14% | -$906,978 | |||||
| D | 2021-06-09 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale+OE | $3.54 | -4,010 | 1,689,060 | 0% | -$14,183 | |||||
2021-05-26 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $2.48 | -16,072 | 2,107,099 | -1% | -$39,889 | ||||||
| M | 2021-06-11 | EMAN | Emagin Corp | Stillwater Holdings LLC | 10% | S - Sale | $3.81 | -216,379 | 4,725,560 | -4% | -$825,176 | |||||
2021-06-09 | EMAN | Emagin Corp | Stillwater Holdings LLC | 10% | S - Sale | $3.54 | -12,019 | 4,941,939 | 0% | -$42,492 | ||||||
| M | 2021-05-28 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $3.25 | -525,100 | 1,581,999 | -25% | -$1,706,565 | |||||
| M | 2021-06-04 | EMAN | Emagin Corp | Stillwater Holdings LLC | 10% | S - Sale | $3.64 | -56,511 | 4,953,958 | -1% | -$205,965 | |||||
| M | 2021-06-11 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $3.79 | -92,050 | 1,597,010 | -5% | -$348,558 | |||||
| D | 2021-06-15 | EMAN | Emagin Corp | Ghosh Amalkumar | COO, SVP | S - Sale+OE | $4.06 | -50,000 | 39,104 | -56% | -$203,010 | |||||
| D | 2021-06-02 | EMAN | Emagin Corp | Saltarelli Joseph | VP | S - Sale+OE | $3.60 | -12,849 | 12,311 | -51% | -$46,256 | |||||
| M | 2021-06-15 | EMAN | Emagin Corp | Stillwater Holdings LLC | 10% | S - Sale | $3.96 | -413,241 | 4,312,319 | -9% | -$1,638,020 | |||||
2021-06-02 | EMAN | Emagin Corp | Stillwater Holdings LLC | 10% | S - Sale | $3.66 | -22,856 | 5,010,469 | 0% | -$83,749 | ||||||
| M | 2021-06-02 | EMAN | Emagin Corp | Ginola Ltd | 10% | S - Sale | $3.66 | -13,131 | 1,568,868 | -1% | -$48,059 | |||||
| D | 2021-06-15 | EMAN | Emagin Corp | Saltarelli Joseph | VP | S - Sale+OE | $3.96 | -20,000 | 12,311 | -62% | -$79,148 | |||||
| DM | 2021-06-14 | EMAN | Emagin Corp | Olivier Prache | SVP | S - Sale+OE | $3.85 | -50,000 | 18,519 | -73% | -$192,431 | |||||
| D | 2021-05-27 | EMPR | Empire Petroleum Corp | Morrisett Michael R. | Pres, 10% | S - Sale+OE | $0.75 | -300,000 | 1,693,128 | -15% | -$225,000 | |||||
| D | 2021-05-27 | EMPR | Empire Petroleum Corp | Pritchard Thomas W. | CEO | S - Sale+OE | $0.75 | -300,000 | 0 | -100% | -$225,000 | |||||
2021-05-26 | EXPR | Express, Inc. | Moellering Matthew C | Pres, COO | S - Sale | $5.00 | -100,000 | 717,947 | -12% | -$500,000 | ||||||
2021-06-14 | FORD | Forward Industries, Inc. | Maiman Mitchell | Pres of Subsidiary | S - Sale | $2.77 | -10,000 | 85,868 | -10% | -$27,663 | ||||||
2021-06-07 | FORD | Forward Industries, Inc. | Severino Paul Jean | COO of Subsidiary | S - Sale | $2.62 | -10,000 | 85,918 | -10% | -$26,228 | ||||||
2021-06-01 | GALT | Galectin Therapeutics Inc | 10X Fund, L.P. | 10% | S - Sale | $3.91 | -10,000 | 6,268,940 | 0% | -$39,100 | ||||||
2021-06-09 | GDMK | Global Diversified Marketing Group Inc. | Adler Paul | CEO, Pres, Secretary, 10% | S - Sale | $2.00 | -1,200,000 | 10,594,322 | -10% | -$2,394,000 | ||||||
2021-05-26 | GHMP | Good Hemp, Inc. | Alessi William Rosario Jr | CEO, 10% | S - Sale | $0.75 | -278,667 | 6,681,547 | -4% | -$208,722 | ||||||
2021-06-08 | GHMP | Good Hemp, Inc. | Alessi William Rosario Jr | CEO, 10% | S - Sale | $0.75 | -64,000 | 6,617,547 | -1% | -$48,000 | ||||||
| D | 2021-06-07 | GNLN | Greenlane Holdings, Inc. | Mote William E. Jr | CFO | S - Sale+OE | $3.94 | -21,650 | 27,956 | -44% | -$85,301 | |||||
2021-05-28 | GNLN | Greenlane Holdings, Inc. | Schoenfeld Adam | Chief Strategy Officer, 10% | S - Sale | $3.90 | -35,000 | 140,401 | -20% | -$136,500 | ||||||
2021-05-26 | GNW | Genworth Financial Inc | Gupta Rohit | EVP - Enact | S - Sale | $4.21 | -60,000 | 97,843 | -38% | -$252,462 | ||||||
2021-05-27 | GNW | Genworth Financial Inc | Bobitz Ward E. | EVP, GC | S - Sale | $4.21 | -90,000 | 272,001 | -25% | -$378,468 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |